These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
173 related articles for article (PubMed ID: 12470806)
21. Microglia contributes to plaque growth by cell death due to uptake of amyloid β in the brain of Alzheimer's disease mouse model. Baik SH; Kang S; Son SM; Mook-Jung I Glia; 2016 Dec; 64(12):2274-2290. PubMed ID: 27658617 [TBL] [Abstract][Full Text] [Related]
22. The role of microglial cells and astrocytes in fibrillar plaque evolution in transgenic APP(SW) mice. Wegiel J; Wang KC; Imaki H; Rubenstein R; Wronska A; Osuchowski M; Lipinski WJ; Walker LC; LeVine H Neurobiol Aging; 2001; 22(1):49-61. PubMed ID: 11164276 [TBL] [Abstract][Full Text] [Related]
23. N-truncated Aβ Wirths O; Walter S; Kraus I; Klafki HW; Stazi M; Oberstein TJ; Ghiso J; Wiltfang J; Bayer TA; Weggen S Alzheimers Res Ther; 2017 Oct; 9(1):80. PubMed ID: 28978359 [TBL] [Abstract][Full Text] [Related]
24. Ube3a deficiency inhibits amyloid plaque formation in APPswe/PS1δE9 mouse model of Alzheimer's disease. Singh BK; Vatsa N; Kumar V; Shekhar S; Sharma A; Jana NR Hum Mol Genet; 2017 Oct; 26(20):4042-4054. PubMed ID: 29016862 [TBL] [Abstract][Full Text] [Related]
25. Amyloidosis in Alzheimer's Disease: Pathogeny, Etiology, and Related Therapeutic Directions. Ma C; Hong F; Yang S Molecules; 2022 Feb; 27(4):. PubMed ID: 35209007 [TBL] [Abstract][Full Text] [Related]
26. Impact of CRFR1 Ablation on Amyloid-β Production and Accumulation in a Mouse Model of Alzheimer's Disease. Campbell SN; Zhang C; Roe AD; Lee N; Lao KU; Monte L; Donohue MC; Rissman RA J Alzheimers Dis; 2015; 45(4):1175-84. PubMed ID: 25697705 [TBL] [Abstract][Full Text] [Related]
27. Alzheimer's Amyloid-β Sequesters Caspase-3 in Vitro via Its C-Terminal Tail. Chang YJ; Linh NH; Shih YH; Yu HM; Li MS; Chen YR ACS Chem Neurosci; 2016 Aug; 7(8):1097-106. PubMed ID: 27227450 [TBL] [Abstract][Full Text] [Related]
28. Persistence of Aβ seeds in APP null mouse brain. Ye L; Fritschi SK; Schelle J; Obermüller U; Degenhardt K; Kaeser SA; Eisele YS; Walker LC; Baumann F; Staufenbiel M; Jucker M Nat Neurosci; 2015 Nov; 18(11):1559-61. PubMed ID: 26352792 [TBL] [Abstract][Full Text] [Related]
29. Trace metal contamination initiates the apparent auto-aggregation, amyloidosis, and oligomerization of Alzheimer's Abeta peptides. Huang X; Atwood CS; Moir RD; Hartshorn MA; Tanzi RE; Bush AI J Biol Inorg Chem; 2004 Dec; 9(8):954-60. PubMed ID: 15578276 [TBL] [Abstract][Full Text] [Related]
30. Alzheimer's Disease-Associated β-Amyloid Is Rapidly Seeded by Herpesviridae to Protect against Brain Infection. Eimer WA; Vijaya Kumar DK; Navalpur Shanmugam NK; Rodriguez AS; Mitchell T; Washicosky KJ; György B; Breakefield XO; Tanzi RE; Moir RD Neuron; 2018 Jul; 99(1):56-63.e3. PubMed ID: 30001512 [TBL] [Abstract][Full Text] [Related]
31. Clusterin promotes amyloid plaque formation and is critical for neuritic toxicity in a mouse model of Alzheimer's disease. DeMattos RB; O'dell MA; Parsadanian M; Taylor JW; Harmony JA; Bales KR; Paul SM; Aronow BJ; Holtzman DM Proc Natl Acad Sci U S A; 2002 Aug; 99(16):10843-8. PubMed ID: 12145324 [TBL] [Abstract][Full Text] [Related]
32. Diffuse amyloid deposition, but not plaque number, is reduced in amyloid precursor protein/presenilin 1 double-transgenic mice by pathway lesions. van Groen T; Liu L; Ikonen S; Kadish I Neuroscience; 2003; 119(4):1185-97. PubMed ID: 12831872 [TBL] [Abstract][Full Text] [Related]
33. Amyloid binding ligands as Alzheimer's disease therapies. Lee VM Neurobiol Aging; 2002; 23(6):1039-42. PubMed ID: 12470800 [TBL] [Abstract][Full Text] [Related]
34. Alzheimer precursor protein interaction with the Nogo-66 receptor reduces amyloid-beta plaque deposition. Park JH; Gimbel DA; GrandPre T; Lee JK; Kim JE; Li W; Lee DH; Strittmatter SM J Neurosci; 2006 Feb; 26(5):1386-95. PubMed ID: 16452662 [TBL] [Abstract][Full Text] [Related]
35. Human tau increases amyloid β plaque size but not amyloid β-mediated synapse loss in a novel mouse model of Alzheimer's disease. Jackson RJ; Rudinskiy N; Herrmann AG; Croft S; Kim JM; Petrova V; Ramos-Rodriguez JJ; Pitstick R; Wegmann S; Garcia-Alloza M; Carlson GA; Hyman BT; Spires-Jones TL Eur J Neurosci; 2016 Dec; 44(12):3056-3066. PubMed ID: 27748574 [TBL] [Abstract][Full Text] [Related]
36. On the origin of Alzheimer's disease. Trials and tribulations of the amyloid hypothesis. Castello MA; Soriano S Ageing Res Rev; 2014 Jan; 13():10-2. PubMed ID: 24252390 [TBL] [Abstract][Full Text] [Related]
37. Biomarker evidence for uncoupling of amyloid build-up and toxicity in Alzheimer's disease. Zetterberg H; Blennow K Alzheimers Dement; 2013 Jul; 9(4):459-62. PubMed ID: 23159047 [TBL] [Abstract][Full Text] [Related]
38. Amyloid-beta and synaptic activity in mice and men. Ihara M; Kalaria RN Neuroreport; 2007 Aug; 18(12):1205-6. PubMed ID: 17632268 [No Abstract] [Full Text] [Related]
39. Nitration of tyrosine 10 critically enhances amyloid β aggregation and plaque formation. Kummer MP; Hermes M; Delekarte A; Hammerschmidt T; Kumar S; Terwel D; Walter J; Pape HC; König S; Roeber S; Jessen F; Klockgether T; Korte M; Heneka MT Neuron; 2011 Sep; 71(5):833-44. PubMed ID: 21903077 [TBL] [Abstract][Full Text] [Related]
40. Microglia limit the expansion of β-amyloid plaques in a mouse model of Alzheimer's disease. Zhao R; Hu W; Tsai J; Li W; Gan WB Mol Neurodegener; 2017 Jun; 12(1):47. PubMed ID: 28606182 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]